Tubal, Zyrahlyn M.

HRN: 28-24-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2026
CEFUROXIME 1.5GM (VIAL)
05/31/2026
06/07/2026
IV
230mg
Q8H
T/C Measles Pneumonia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines